Faculty profile

Amit Oza

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Amit Oza

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
23 publications in the last five years, latest in 2026.
Principal investigator on 3 research grants (3 CIHR), most recently in 2022.
Supervised 1 trainee who won CIHR awards, most recently in 2017.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

497

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Adaptive Trials Biostatistics Clinical Trials Hqp Development Job Shadowing Mentorship Pedogagy Training

Latest papers

Gynecologic Cancer InterGroup code of conduct for diversity in gynecological cancer trials: a clinical guide from the Berlin Gynecologic Cancer InterGroup meeting.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2026
GLI1 -Rearranged Tumors of the Gynecologic Tract : A Detailed Clinicopathologic Study of 10 Cases.
The American journal of surgical pathology · 2026
Factors influencing care for patients with gynecologic malignancies from culturally and linguistically diverse backgrounds: a questionnaire study (iCALD-2).
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026

All 71 publications

Latest funding

A randomized controlled trial of early outpatient palliative care for patients with multiple myeloma
CIHR · 2026 · Co-investigator
$761,176
MitoRevolution: Mitochondrial Transplantation Transforming Regenerative Medicine - from research to patient care to global impact.
SSHRC · 2024 · Co-investigator
$3,934,956
Canadian Training Platform for Trials Leveraging Existing Networks (CAN-TAP-TALENT)
CIHR · 2022 · Principal investigator
$4,314,242

All 14 grants and awards

71 publications.

Gynecologic Cancer InterGroup code of conduct for diversity in gynecological cancer trials: a clinical guide from the Berlin Gynecologic Cancer InterGroup meeting.

Sehouli J, Bookman MA, Harter P, Oza A, Brand A, Fidalgo JA, Sur DB, Lee MM, Louwen F, Zeimet A, Mukhopadhyay A, O'Donnell J, Pothuri B, Gynecologic Cancer InterGroup (GCIG)

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society2026

DOI: 10.1016/j.ijgc.2026.104830 PMID: 42556209

GLI1 -Rearranged Tumors of the Gynecologic Tract : A Detailed Clinicopathologic Study of 10 Cases.

Zyla RE, Howitt BE, Bosse T, van Slooten FE, Oza A, Ma D, Kolin DL, Croce S, Merck L, Buist H, Arora R, Karnezis A, Alnuaim H, Hodgson A, McCluggage WG, Clarke BA

The American journal of surgical pathology2026

DOI: 10.1097/pas.0000000000002545 PMID: 41928465

Factors influencing care for patients with gynecologic malignancies from culturally and linguistically diverse backgrounds: a questionnaire study (iCALD-2).

Kasherman L, Braik D, Gonzalez-Ochoa E, Shukla A, Odujoko O, Lajkosz K, Wang C, Grant R, Dhani N, Bowering V, Croke J, Philp L, Oza A, Lheureux S

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

DOI: 10.1007/s00520-026-10881-x PMID: 42307686

Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.

Drew Y, Gilbert L, Martinez Bueno A, Oaknin A, Moreno V, Gaba Garcia L, Jayson GC, Kristeleit RS, Lakhani N, Banerjee S, Matei D, Oza A, Miller R, Yiannakis D, Barretina-Ginesta MP, Martínez García J, Wang G, Miriyala J, Franke A, Galvez E, Pandite L, Richardson DL

British journal of cancer2026

DOI: 10.1038/s41416-026-03430-0 PMID: 41951722

Reporting and enrollment disparities in hematologic malignancy trials between 2000-2023.

Gong IY, Rafinejad-Farahani B, Majeed H, Soto MJ, Oza A, Ehrlich T, Fernandez Lynch H, Guerra CE, Lofters A, Unger JM, Conti RM, Rosenthal M, Rodin D

Leukemia & lymphoma2026

DOI: 10.1080/10428194.2025.2579735 PMID: 41178673

Disparities in clinical trial participation among older adult Medicare beneficiaries with hematologic malignancies from 2006 to 2019: A SEER-Medicare analysis.

Gong IY, Soto MJ, Rafinejad-Farahani B, Unger JM, Conti RM, Guerra CE, Oza A, Rosenthal M, Rodin D

Cancer2025

DOI: 10.1002/cncr.70204 PMID: 41368947

Overall survival with maintenance olaparib in platinum-sensitive relapsed ovarian cancer by somatic or germline BRCA and homologous recombination repair mutation status.

Pignata S, Oza A, Hall G, Pardo B, Madry R, Cibula D, Klat J, Montes A, Glasspool R, Colombo N, Pete I, Herrero Ibáñez A, Romeo M, Ilieva R, Timcheva C, Di Maio M, Bashir Z, Taylor R, Barnicle A, Clamp A

British journal of cancer2025

DOI: 10.1038/s41416-025-02966-x PMID: 40097725

ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety.

Matulonis UA, Herrstedt J, Oza A, Mahner S, Redondo A, Berton D, Berek JS, Haslund CA, Marmé F, González-Martín A, Bécourt S, Tinker AV, Ledermann JA, Benigno B, Lindahl G, Colombo N, Malinowska IA, Liu W, Bains M, Monk BJ, Mirza MR

Gynecologic oncology2025

DOI: 10.1016/j.ygyno.2025.03.018 PMID: 40139026

Perspectives on inclusion, diversity, equity, and access in clinical trials: findings from a 6-continent survey.

Dimitrova D, Boer J, Karaman M, Bookman M, Brand A, O'Donnell J, Oza A, Pothuri B, Bennett K, Sehouli J

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society2025

DOI: 10.1016/j.ijgc.2024.101625 PMID: 39971426

High-grade serous ovarian cancer-bridging the gap between epidemiology and prevention with biology.

Bauer S, Oza A, Lheureux S

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society2025

DOI: 10.1016/j.ijgc.2025.101662 PMID: 39923639

A randomized controlled trial of early outpatient palliative care for patients with multiple myeloma

Co-investigatorCIHR2026Project Grant

Principal investigators: Hannon, Breffni

Keywords: Early Palliative Care; Malignant Hematology; Multiple Myeloma; Quality Of Life; Randomized Controlled Trial; Satisfaction With Care; Supportive Care; Symptom Control

$761,176

MitoRevolution: Mitochondrial Transplantation Transforming Regenerative Medicine - from research to patient care to global impact.

Co-investigatorSSHRC2024New Frontiers in Research Fund - Transformation

Principal investigators: Andreazza, Ana

$3,934,956

Canadian Training Platform for Trials Leveraging Existing Networks (CAN-TAP-TALENT)

Principal investigatorCIHR2022Training Grant: Clinical Trials Training Platforms

Principal investigators: Cheung, Angela M; Ahmed, Sofia B; Allen, Upton D; Bhat, Mamatha; Boyd, Steven K; Crawley, Angela M; Dolatabadi, Elham; Fahim, Christine; Farkouh, Michael E; Feld, Jordan J; Fox, Susan; Furlan, Andrea D; Goligher, Ewan C; Hodgson, David C; Inman, Robert D; Juando Prats, Clara; Lamontagne, Francois; Langlois, Marc-Andre; Levin, Adeera; Mansfield, Avril; Manske, Sarah L; McMaster, W. Robert; Mylopoulos, Maria; Oza, Amit M; Papaioannou, Alexandra; Pinto, Andrew D; Quinn, Kieran L; Rahman, Proton; Razak, Fahad; Richard, Nicolas; Richardson, Harriet; Sander, Beate H; Sellmann, Susanna; Stelfox, Henry T; Straus, Sharon E; Tartaglia, Maria Carmela; Tobe, Sheldon W; Tomlinson, George A; Verma, Amol; Walmsley, Sharon L; Wu, Robert; Xu, Wei

Keywords: Adaptive Trials; Biostatistics; Clinical Trials; Hqp Development; Job Shadowing; Mentorship; Pedogagy; Training

$4,314,242

Long COVID Web: Pan-Canadian Post-COVID Condition Research Network

Co-investigatorCIHR2022Operating Grant: Canadian Post COVID-19 Condition Research Network

Principal investigators: Cheung, Angela M; Goulding, Susie E; Graves, Donna Lorraine; Archambault, Patrick; Awadalla, Philip; Bakal, Jeffrey A; Bhéreur, Anne; Brotto, Lori Anne; Busse, Jason W; Cameron, Jill I; Churchill, Katie; Crawley, Angela M; Décary, Simon; Durand, Madeleine; Falcone, Emilia L; Fowler, Robert A; Gommerman, Jennifer L; Graham, Kathryn E; Graham, Simon J; Groot, Gary; Gross, Douglas P; Guyatt, Gordon H; Halas, Gayle; Ho, Chester; Hohl, Corinne M; Holroyd, Brian R; Janjua, Naveed Z; Johnson, Pauline; Juando Prats, Clara; Kashuba, Sherri; Katz, Alan; Kho, Michelle E; Lam, Grace Y; Lamontagne, Francois; Langlois, Marc-Andre; Lavis, John N; Law, Susan K; LeBlanc, Annie; Levin, Adeera; Liu-Ambrose, Teresa Y; Liu, Peter P; Lix, Lisa M; Mandhane, Piush; Mann, Balraj; McGrail, Kimberlyn M; McNagny, Kelly M; Miciak, Maxi A; Mishra, Sharmistha; Muhajarine, Nazeem; Mukherjee, Manali; Mushquash, Christopher J; Nacul, Luis; O'Brien, Kelly K; Osgood, Nathaniel D; Papathanasoglou, Elisavet; Penninger, Josef; Piche, Alain; Pinto, Andrew D; Quinn, Kieran L; Rafferty, Ellen; Raj, Satish R; Razak, Fahad; Russell, James A; Sander, Beate H; Sekuler, Allison B; Soares, Claudio D; Tailfeathers, Esther; Tomlinson, George A; Tricco, Andrea C; Valdez, Yanet; Verma, Amol; Vohra, Sunita; Walmsley, Sharon L; Walsh, Jillian; Weeks, Laura C; Williams, Kienan; Wu, Jianhong; Yeung, Rae S

Keywords: Biobanking; Knowledge Translation; Long Covid; Mechanism Of Disease; National Network; Patient Engagement; Patient Registries; Post-Covid Condition; Research Communications; Social Determinants Of Health

$19,999,614

Canadian Training Platform for Trials Leveraging Existing Networks (CAN-TAP-TALENT)

Principal investigatorCIHR2022Training Grant: Clinical Trials Training Platforms - Indirect Costs

Keywords: Adaptive Trials; Biostatistics; Clinical Trials; Hqp Development; Job Shadowing; Mentorship; Pedogagy; Training

$1,078,562

The RECLAIM (REcovering from COVID-19 Lingering symptoms Adaptive Integrative Medicine) trial

Co-investigatorCIHR2021Op Grant: Emerging COVID-19 Research Gaps & Priorities - Post COVID-19 condition

Principal investigators: Cheung, Angela M; Jüni, Peter; Tomlinson, George A

Keywords: Adaptive Randomized Clinical Trial; Anti-Inflammatory, Antiviral, Immunomodulatory Therapies; Integrative Medicine; Physical Function, Re-Integration To Normal Living; Post-Acute Sequelae Of Covid-19 (Pasc); Post-Covid Condition (Long Covid); Post-Covid-19 Functional Status Scale (Pcfs); Symptom Checklists, Health-Related Quality Of Life; Traditional Chinese Medicine; Vitamins And Supplements

$1,000,000

Tailored adjuvant therapy in POLE-mutated and p53-wildtype early stage endometrial cancer (TAPER)

Co-investigatorCIHR2020Project Grant

Principal investigators: Han, Kathy; Mcalpine, Jessica N

Keywords: Clinical Trial; De-Escalation Therapy; Decisional Conflict; Endometrial Cancer; Molecular Biomarker; P53/Tp53; Personalized Cancer Treatment; Pole; Quality Of Life; Translational Research

$1,082,474

Viral mimicry tolerance as a mechanism of early tumor immune evasion

Co-investigatorCIHR2019Project Grant

Principal investigators: De Carvalho, Daniel

Keywords: Cancer; Dna Methylation; Epigenetics; Histone Methylation; Immunotherapy; Ovarian Cancer; Therapy Resistance

$868,276

Cancer Patient Autonomy & Decision-Making in Early-Phase Trial Recruitment

Co-investigatorCIHR2017Catalyst Grant: Ethics

Principal investigators: Bell, Jennifer

Keywords: Cancer; Clinical Trials; Ethics; Informed Consent; Patient Decision Making; Qualitative Research Methods; Tool Development

$99,982

A multi-phase clinical trial to establish biological proof-of-concept, determine safety and maximum tolerated dose, and assess efficacy of neoadjuvant ketoconazole and posaconazole in patients with recurrent high grade gliomas

SupervisorCIHR2017CIHR Fellowship

Principal investigators: Mansouri, Alireza

Keywords: Clinical Trial; Neo-Adjuvant Therapy; Neuro-Oncology

$220,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Amit Oza

Research

Latest papers

Latest funding

Gynecologic Cancer InterGroup code of conduct for diversity in gynecological cancer trials: a clinical guide from the Berlin Gynecologic Cancer InterGroup meeting.

GLI1 -Rearranged Tumors of the Gynecologic Tract : A Detailed Clinicopathologic Study of 10 Cases.

Factors influencing care for patients with gynecologic malignancies from culturally and linguistically diverse backgrounds: a questionnaire study (iCALD-2).

Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.

Reporting and enrollment disparities in hematologic malignancy trials between 2000-2023.

Disparities in clinical trial participation among older adult Medicare beneficiaries with hematologic malignancies from 2006 to 2019: A SEER-Medicare analysis.

Overall survival with maintenance olaparib in platinum-sensitive relapsed ovarian cancer by somatic or germline BRCA and homologous recombination repair mutation status.

ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety.

Perspectives on inclusion, diversity, equity, and access in clinical trials: findings from a 6-continent survey.

High-grade serous ovarian cancer-bridging the gap between epidemiology and prevention with biology.

MitoRevolution: Mitochondrial Transplantation Transforming Regenerative Medicine - from research to patient care to global impact.

Frequent collaborators

Stephanie Lheureux

Lisa Wang

David Hedley

Gregory Pond

Michael Milosevic

Holger Hirte

Barry Rosen

Danielle Rodin

Carol Swallow

Eitan Amir

Michael Brudno

John Kim

Lillian Siu

Ming-Sound Tsao

Tracy Stockley

Christopher Lo

Glenwood Goss

Allan Donner

Jennifer Croke

Laura Dawson

Robert Grant

Tony Panzarella

Myron Cybulsky

Catherine O'Brien

Michelle Nelson

Paula Rochon

Gary Rodin

Camilla Zimmermann

Allison McGeer

Michelle Nelson

Bradly Wouters

Neesha Dhani

Anne-Marie Mes-Masson